OUR PRODUCTS
Currently approved in Australia and / or New Zealand
Vivotif Oral is for the prevention of typhoid in adults and children above 6 years of age.
For information regarding Vivotif , including the Therapeutic Goods Administration (TGA) approved Consumer Medical Information and Product Information (for health professionals only), please click the button below.
®
®
Kodatef is approved for malaria prevention (prophylaxis) when travelling to areas where malaria is present. For information regarding Kodatef, including the Therapeutic Goods Administration (TGA) approved Consumer Medical Information and Product Information (for health professionals only), please click the button below.
RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than 2 days.
For information regarding RAPIVAB, including the Therapeutic Goods Administration (TGA) approved Consumer Medical Information and Product Information (for health professionals only), please click the button below.
®
®
STANDARD Q COVID-19 Ag Test is a rapid point of care chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx. This test is for administration by healthcare workers and approved laboratories only, as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms with SARS-CoV-2 infection.
